The Editor-in-Chief’s Letter—Diagnostics Receives an Updated Impact Factor of 3.3

Dear Editorial Board Members, Guest Editors, Authors, and Reviewers,

It is with great pleasure that I share the news that Diagnostics (ISSN: 2075-4418) has received an increased Impact Factor of 3.3 for 2024 (JCR Q1, 57/332). Diagnostics also received an increased CiteScore of 5.9 (marking the fifth consecutive year of growth). This continued growth reflects your invaluable contributions, unwavering support, and commitment to scientific excellence.

I would like to extend my sincere gratitude to each of you for your dedication, insightful reviews, and high-quality submissions. Together, we have strengthened the journal’s visibility, scientific impact, and community.

I look forward to building further on this momentum and to our continued collaboration in the coming years.

Best regards,
Professor Andreas Kjaer
Editor-in-Chief, Diagnostics